🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSemaglutide (Ozempic / Wegovy)A1C reduction on semaglutide: SUSTAIN program meta-analysis Page 5

A1C reduction on semaglutide: SUSTAIN program meta-analysis

A1cHero_PHX Tue, May 19, 2026 at 4:00 AM 22 replies 520 viewsPage 5 of 5
josh_phd_bmore
Member
389
1,678
Jul 2024
Baltimore, MD
May 27, 2026 at 2:55 AM#21

Adding the numbers, since they settle part of this. Practical: whatever you change, write down the date and the reason. In three months the reason is what you will have forgotten, and the reason is what makes the record worth having.

Worth separating that from the trial evidence, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

Last edited: May 27, 2026 at 4:55 AM
47 20NurseKim_ATL, paul_denver, TinaHashiRN and 44 others
Reply Quote Save Share Report
patPC_UT
Member
212
890
Nov 2024
Park City, UT
May 29, 2026 at 10:14 PM#22

One thing that is still open after SleepDoc_PDX’s answer:

What the dose-response curve actually looks like above 1.7mg, because the trial means hide how few people account for the extra loss?

48 21mike.trainer_LA, sarah_nash92, FitDadDave and 45 others
Reply Quote Save Share Report
HealthEcon_DC
Member
567
3,456
Apr 2024
Washington, DC
Jun 1, 2026 at 5:31 PM#23
josh_phd_bmore said:
Practical: whatever you change, write down the date and the reason.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. I would add the less popular caveat: these trial populations under-represented several groups, older adults and the highest BMI categories among them. The results probably generalise, and "probably" should be stated as an assumption rather than dropped.

That is the short version; the long version is somebody else's post.

Last edited: Jun 1, 2026 at 7:31 PM
49 22KevinCompounds, TirzTom, TrialTracker_MD and 46 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
sarah_nash92
Member
712
3,123
Jun 2024
Nashville, TN
Jun 4, 2026 at 12:46 PM#24
josh_phd_bmore said:
Practical: whatever you change, write down the date and the reason.

That is correct as far as it goes, and here is where it stops going. Yes, and the corollary is less popular: if the reasoning holds, it also holds where it produces an answer we do not like.

50 23CanadaChris, ZaraB_AL, JakeSmashed95 and 47 others
Reply Quote Save Share Report
SkepticalSean
Member
98
345
Jan 2025
Maine
Jun 7, 2026 at 8:00 AM#25
josh_phd_bmore said:
Practical: whatever you change, write down the date and the reason.

That reframing is the part I needed.

1 24Dr.LipidDallas
Reply Quote Save Share Report
1345

Similar Threads

STEP 1-5 trials comprehensive summary — efficacy endpoints compiled12 replies
Oral semaglutide 50mg Phase 3 — OASIS program results16 replies
Semaglutide pharmacokinetics — half-life, Tmax, steady state modeling10 replies
Compounded semaglutide stability data — temperature and light sensitivity16 replies
0.25mg → 2.4mg titration: optimal schedule based on clinical data6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register